Company Filing History:
Years Active: 1997
Title: The Innovations of Sergio Gloor
Introduction
Sergio Gloor is a notable inventor based in Basle, Switzerland. He has made significant contributions to the field of neuroscience through his innovative work. His research focuses on the treatment of lesions in the nervous system, showcasing his dedication to advancing medical science.
Latest Patents
Sergio Gloor holds a patent for a method of treating lesions in the nervous system. This invention relates to a neurite-promoting factor released by glial cells. It includes related proteins and fragments that retain their neurite-promoting activity. The patent also covers DNAs coding for the amino acid sequence of the neurite-promoting factor and fragments thereof. Additionally, it involves hybrid vectors containing such DNAs, hosts transformed with these hybrid vectors, and processes for preparing the DNAs, vectors, and transformed hosts. The invention aims to manufacture the neurite-promoting factor, related proteins, and their fragments for use in treating nervous system lesions. Gloor's patent is a testament to his innovative approach to addressing complex medical challenges.
Career Highlights
Sergio Gloor is currently associated with Incyte Pharmaceuticals, Inc., where he continues to contribute to groundbreaking research. His work at Incyte emphasizes the importance of collaboration and innovation in the pharmaceutical industry. Gloor's expertise in neuroscience and his commitment to developing effective treatments have positioned him as a valuable asset in his field.
Collaborations
Sergio Gloor collaborates with Karel Gerrit Odink, enhancing the scope and impact of their research endeavors. Their partnership exemplifies the power of teamwork in driving scientific advancements.
Conclusion
Sergio Gloor's contributions to the field of neuroscience through his innovative patent and work at Incyte Pharmaceuticals highlight his commitment to improving medical treatments. His research continues to pave the way for advancements in the treatment of nervous system lesions.